Navigation Links
Regenicin Appoints Renowned New York Dermatologist, Dr. Gervaise Gerstner to Scientific Advisory Board
Date:10/27/2010

NEW YORK, Oct. 27 /PRNewswire-FirstCall/ -- Regenicin, Inc. (OTC Bulletin Board: WDST), a development stage company focusing on next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin, announced today the appointment of Dr. Gervaise Gerstner to the company's Scientific Advisory Board. Dr. Gerstner is a board-certified dermatologist and Assistant Clinical Professor of Dermatology at Mount Sinai Hospital in New York.

Dr. Gerstner earned her M.D. from Mount Sinai Medical School in New York City and completed a dermatology residency at Mount Sinai Hospital, where she was chosen to serve as Chief Resident of Dermatology. She is an associate member of the American Academy of Dermatology and the American Academy of Dermatologic Surgeons, and is a member of both the Dermatology Foundation and the Skin Cancer Foundation.  

"Dr. Gerstner brings more than ten years of clinical dermatology experience to our board," says Randall McCoy, CEO of Regenicin. "We are certain she will play a pivotal role in guiding the development of new applications, markets and technologies for the treatment of skin."

Dr. Gerstner, who is one of the world's first doctors trained in the highly advanced Fraxel laser, has conducted research on a wide range of topics from chemical peels to melanoma. Her work has been published in leading dermatologic journals and she served as book editor for Clinics in Dermatology. She is also regularly featured in national and regional media including W Magazine, Harper's Bazaar, Allure, Glamour, Self, New York and Real Simple.

"I worked closely with burn patients in medical school and during my residency, and continue to do so in my current practice," says Dr. Gerstner. "I am delighted to be part of a company that is on the cutting-edge of making life-saving technologies available for the treatment chronic burns and wounds."

About Regenicin, Inc.

Regenicin, Inc. is a development stage biotechnology company. Regenicin is a publicly traded company, with headquarters in New York. Additional information can be found in the company's filings with the Securities and Exchange Commission located at www.sec.gov.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Regenicin, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Regenicin to Form Scientific Advisory Board
2. Regenicin Names Former U.S. Marine Corp Operations Officer, Christopher Hadsall, Chief Operating Officer
3. Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO
4. Regenicin Completes Acquisition of Worldwide Exclusive Know-How Technology License from Lonza Walkersville
5. Bacterin International Reconstitutes Its Board of Directors and Appoints Experienced Legal and Financial Professionals
6. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
7. caprotec bioanalytics GmbH Appoints Prof. Dr. Rainer Metternich as Managing Director, Chief Business Officer and Chief Operating Officer
8. Resverlogix Appoints Kenneth J. Zuerblis to Board of Directors
9. Generex Biotechnology Appoints Mark Fletcher as Interim President and CEO, and John P. Barratt as Chairman of the Board
10. EUCODIS Bioscience Appoints Two Industry Executives to Realigned Advisory Board
11. ONCOTHYREON APPOINTS JULIE M. EASTLAND AS CHIEF FINANCIAL OFFICER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... WASHINGTON , Feb. 11, 2016   BioInformant ... strategic report, "Stem Cell Research Products, Opportunities, Tools, and ... 2020. ... specialize in the stem cell industry, BioInformant has more ... of the stem cell market, by stem cell type. ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... its new stem cell treatment clinic in Quito, Ecuador. The new facility will ... trauma applications to patients from around the world. , The new GSCG ...
(Date:2/10/2016)... 10, 2016  The Maryland House of Delegates and ... that University of Maryland School of Medicine Dean ... of Maryland Medical System President and CEO Robert ... the highest honor given to the public by the ... Dean Reece and Mr. Chrencik for their contributions ...
(Date:2/10/2016)... York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has ... develop new vaccines and immunotherapies for infectious diseases and cancer. , ...
Breaking Biology Technology:
(Date:2/11/2016)... , Feb. 11, 2016  Vigilant Solutions announces today that ... are being used by Lee,s Summit ... recent location and arrest of a homicide suspect. ... covers around 65 square miles and is home to ... Department has a single mobile license plate reader system and ...
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/3/2016)... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ... "Emotion Detection and Recognition Market by Technology ... Tools (Facial Expression, Voice Recognition and Others), ... Global forecast to 2020" report to ... ) has announced the addition of the ...
Breaking Biology News(10 mins):